← Leaderboards
Mohammad S. Jalali
Massachusetts General Hospital
$4,041,402
Attributed
$4,584,261
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
FDA$3,498,542 · 3
CDC$1,085,719 · 1
By mechanism
U01$3,498,542 · 3
R01$1,085,719 · 1
Top collaborators
- Arielle R. Deutsch3 shared
Grant awards (7)
A community-based systems science approach to assess risk and protective factors and improve the efficacy and equity of intervention strategies for stimulant use, use disorder, and overdose$362,096
R01 · FY2023 · CE · contact PI
A community-based systems science approach to assess risk and protective factors and improve the efficacy and equity of intervention strategies for stimulant use, use disorder, and overdose$361,467
R01 · FY2022 · CE · contact PI
Enhancing FDA's opioids systems modeling efforts to more comprehensively address fentanyl, stimulants, polysubstance use, and associated outcomes$1,249,220
U01 · FY2021 · FD · contact PI
A community-based systems science approach to assess risk and protective factors and improve the efficacy and equity of intervention strategies for stimulant use, use disorder, and overdose$362,156
R01 · FY2021 · CE · contact PI
Assessing the impact of COVID-19 on opioid crisis and incorporating it in the FDA's opioids systems model$249,950
U01 · FY2021 · FD · contact PI
Expanding FDA's Opioids Systems Model to Enable Economic Evaluations and Outcome Analyses of National Opioid Policies$999,840
U01 · FY2020 · FD · contact PI
Using System Dynamics to Enhance the FDA's Opioids Systems Model and Address the Ongoing Crisis$999,532
U01 · FY2019 · FD · contact PI